Top

Journal of Diabetes & Metabolic Disorders

Published in:

22-12-2022 | Insulins | Research article

Validation of standardized polyherbal formulation in the management of type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial

Authors: Shridhar Pandya, Chetan Savaliya, Kamlesh Thummar, Amol Gothwad, Tanuja Panchabhai, Dheeraj Nagore

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2023

Abstract

Background

Diabetes is prevalent globally; India stands amongst the first two countries with the highest percentage of adults aged 20–79 years with diabetes in 2021. Anti-diabetic agents and insulin offer profound side effects. Phytoconstituents regulate blood sugar, improve health status and reduce dependency on anti-diabetic medications. This research aims to generate clinical evidence of Diabetic Support Product (GP/PROD/2021/001) in the treatment of type 2 diabetes.

Trial design

A randomized, double-blind, placebo-controlled clinical trial was conducted on 150 individuals with type 2 diabetes mellitus. Subjects were divided into two parallel groups and given either GP/PROD/2021/001 or a placebo tablet; 2 tablets twice a day after meals for 90 days.

Methods

Interventions were adjuvant to the standard medication. The research objectives were to evaluate changes in fasting and post-meal plasma glucose and HbA1c in patients with type 2 diabetes.

Results

In 90 days, GP/PROD/2021/001 group showed a substantial improvement in all key biochemical markers-HbA1c, FBS, and PPBS when compared to the placebo group. A reduced HOMA-IR score suggests reduced insulin resistance. Quality of life improved in GP/PROD/2021/001 group than placebo. On day 90, there was a significant decrease in HbA1c levels in GP/PROD/2021/001 (23.51%) group than placebo (6.21%). The test group reduced their dependency on conventional antidiabetic medication and insulin.

Conclusion

It can be concluded from the study that the advanced diabetic support formula (GP/PROD/2021/001) is a safer and more effective option as an adjuvant in the management of diabetes from newly diagnosed to chronic diabetic patients.

Trial registration

CTRI/2022/01/039179 [Registered on: 05/01/2022] Trial Registered Prospectively.

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: Global, regional, and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https://doi.org/10.1016/j.diabres.2021.109119.CrossRefPubMed

Southwell A, Eckland D. Limitations of treatments available for the management of type 2 diabetes: results from an international survey of physicians. Pract Diabetes Intl. 1998;15(4):112–6.CrossRef

Mukherjee S, Sharmasarkar B, Das KK, Bhattacharyya A, Deb A. Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in Kolkata, India. J Clin Diagn Res. 2013;7(4):661–5. https://doi.org/10.7860/JCDR/2013/5352.2876.

Valerón PF, de Pablos-Velasco PL. Limitaciones de los fármacos dependientes de insulina para el tratamiento de la diabetes mellitus tipo 2 [Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus]. Med Clin (Barc). 2013;141 Suppl 2:20–5. Spanish. https://doi.org/10.1016/S0025-7753(13)70059-9.

Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes. 2010;1(3):68–75. https://doi.org/10.4239/wjd.v1.i3.68.CrossRefPubMedPubMedCentral

Jha P, Kumari S, Jobby R, Desai N, Ali A. Dietary phytonutrients in the prevention of diabetes-related complications. Curr Diabetes Rev. 2020;16(7):657–73.CrossRefPubMed

Sung KC, Reaven GM, Kim SH. Utility of homeostasis model assessment of beta-cell function in predicting diabetes in 12,924 healthy Koreans. Diabetes Care. 2010;33(1):200–2 https://doi.org/10.2337/dc09-1070.

Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245–51. https://doi.org/10.4274/Jcrpe.1127.CrossRefPubMedPubMedCentral

Prajapati VB, Blake R, Acharya LD, Seshadri S. Assessment of quality of life in type II diabetic patients using the modified diabetes quality of life (MDQoL)-17 questionnaire. Braz J Pharm Sci. 2018;5:53.

10.

Pandya S, Savaliya C, Ganu G, Thummar K, Raykantiwar A, Shekhar A. Impact of Gplife advanced diabetic support tablet in diabetes mellitus treatment in a single-arm, prospective clinical trial. Innov Pharm Pharmacother 2021;9(4):69–75.

11.

Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm. 2003;60(4):356–9.CrossRefPubMed

12.

Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. 2007;459(2):214–22.CrossRefPubMed

13.

George CM, Bruijn LL, Will K, Howard-Thompson A. Management of blood glucose with noninsulin therapies in type 2 diabetes. Am Fam Physician. 2015;92(1):27–34.PubMed

14.

Gillett MJ. International expert committee report on the role of the A1c assay in the diagnosis of diabetes: diabetes care 2009; 32 (7): 1327–1334. Clin Biochem Rev. 2009;30(4):197.

15.

Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidemia. Clin Exp Med. 2007;7(1):24–9.CrossRefPubMed

16.

Khan F, Sarker MM, Ming LC, Mohamed IN, Zhao C, Sheikh BY, Tsong HF, Rashid MA. A comprehensive review on phytochemicals, pharmacological and clinical potentials of Gymnema Sylvestre. Front Pharmacol. 2019;10:1223.

17.

Neelakantan N, Narayanan M, de Souza RJ, van Dam RM. Effect of fenugreek (Trigonella foenum-graecumL.) intake on glycemia: a meta-analysis of clinical trials. Nutr J. 2014;13(1):1–1.

18.

Najdi RA, Hagras MM, Kamel FO, Magadmi RM. A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes. Afr Health Sci. 2019;19(1):1594–601.CrossRefPubMedPubMedCentral

19.

Durg S, Bavage S, Shivaram SB. Withania somnifera (Indian ginseng) in diabetes mellitus: a systematic review and meta-analysis of scientific evidence from experimental research to clinical application. Phytother Res. 2020;34(5):1041–59.CrossRefPubMed

20.

Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013:636053. https://doi.org/10.1155/2013/636053.

21.

Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Mobarhan MG, Oskuee RK. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed. 2016;6(5):567.PubMedPubMedCentral

22.

Roxo DF, Arcaro CA, Gutierres VO, Costa MC, Oliveira JO, Lima TF, Assis RP, Brunetti IL, Baviera AM. Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats. Diabetol Metab Syndr. 2019;11(1):1–8.CrossRef

23.

Roy K. Tinospora cordifolia stem supplementation in diabetic dyslipidemia: an open-labeled randomized controlled trial. Funct Foods Health Dis. 2015;5(8):265–74.CrossRef

24.

Shivaprakash G, Pai MR, Nandini M, Reshma K, Sahana DA, Rajendran K, Shirwaikar A, Prabha MA, Ganesh J. Antioxidant Potential of Eugeniajambolana Seed; A Randomized Clinical Trial in type 2 Diabetes Mellitus. Int J Pharma Bio Sci. 2011;2(2):B-220.

Title: Validation of standardized polyherbal formulation in the management of type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
Authors: Shridhar Pandya
Chetan Savaliya
Kamlesh Thummar
Amol Gothwad
Tanuja Panchabhai
Dheeraj Nagore
Publication date: 22-12-2022
Publisher: Springer International Publishing
Keywords: Insulins
Diabetes
Insulins
Type 2 Diabetes
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2023
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-022-01171-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Trial design

Methods

Results

Conclusion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2023

Machine learning framework for atherosclerotic cardiovascular disease risk assessment

The combined role of diabetes and obesity in susceptibility to musculoskeletal disorders and its subtypes in older men and women in India

The role of protein kinases in diabetic neuropathic pain: an update review

Health literacy and self-efficacy of the elderly with diabetes

Adoption of IWGDF guidance on prevention and management of foot problems in diabetes for local use in Iran by ADAPTE methodology: a step toward best practice

Hybrid adaptive deep learning classifier for early detection of diabetic retinopathy using optimal feature extraction and classification

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials